Facebook, vilified by all, even in Silicon Valley
Facebook reviled by the Silicon Valley while the industry thrives on the use of personal data posted online (Photo LOIC VENANCE. AFP) The Silicon Valley is not the
Facial recognition : how our faces are being tracked down
Our face is the source of ethics to the fact that he is naked, expressive, gifted with human speech and seems to say to us : “You don’t
Atlantia is going to take an interest in Cellnex
© Reuters. ATLANTIA IS GOING TO TAKE AN INTEREST IN CELLNEX MILAN (Reuters) – The Italian group infrastructure Atlantia announced on Friday that it decided to exercise its
Video game : the social protest is becoming more international
Forty-six years after its beginnings as an industry, the video game has finally its “international” ? The Game Workers Unite (GWU), the first global structure of the defence
Wall Street gives way again to the fears of trade war
© Reuters. WALL STREET ENDS LOWER by Sinéad Carew NEW YORK (Reuters) – The New York stock Exchange has once again folded Friday in the face of fears
The press anglo-saxon “remarks on the” mea-culpa-but-not-too ” – Mark Zuckerberg
His speech was expected, but it is far from having silenced the critics. Nearly a week after the investigations by the Guardian and the New York Times, which
The gallery Soft goes to liquidation prior to a possible recovery
The group Sweet, in discussion with the Ukrainian MHP, account be placed in liquidation in early April, before a possible continuation of the activity, has it learned Friday
Novartis: positive opinion for a biosimilar Sandoz
© Reuters. Novartis: positive opinion for a biosimilar Sandoz Sandoz, a subsidiary of Novartis (SIX:NOVN), has indicated that the european Committee of medicinal products for human use (CHMP)
“We, the insurers, are ready to offer all of our fellow citizens decent care at an acceptable cost “
Forum. For half a century, the French ask, because, why the health of their teeth, their sight, their hearing loss is not covered, the equal of other conditions.
Novo Nordisk: Ozempic approved in Japan against diabetes
© Reuters. Novo Nordisk: Ozempic approved in Japan against diabetes Novo Nordisk (CO:NOVOb) said Friday it has obtained the green light from health authorities in japan for the